During the past decade, Division of Hematology/Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Hematology/Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Division of Hematology/Oncology" are "Colorectal Cancer" (2 trials), "Bladder Cancer" (1 trials), "Lung Cancer" (1 trials), "Malignant Mesothelioma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Division of Hematology/Oncology" in a lesser frequency.

Most popular intervention types in "Division of Hematology/Oncology" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "semaxanib" (3 trials), "CPT-11" (1 trials), "O6-benzylguanine" (1 trials), "carmustine" (1 trials) and "cyclosporine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Hematology/Oncology" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Division of Hematology/Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Division of Hematology/Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Division of Hematology/Oncology, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".